Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
31.05.24
/
50%
€413.40
Target price
31.05.25
€459.80
Performance (%)
8.67%
Price
08:00
€449.25
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 8.67%. This prediction currently runs until 31.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.211% | -0.211% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
Comments by BMO_Capital_Markets for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $480.00 to $500.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.80
07.11.23
07.11.23
€388.11
07.11.24
07.11.24
25.56%
08:00
08:00
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
37.24%
08:00
08:00